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Abstract 
Background: Targeted malaria control interventions are expected to be cost-effective. Clinical, parasitological and 
serological markers of malaria transmission have been used to detect malaria transmission hotspots, but few studies 
have examined the relationship between the different potential markers in low transmission areas. The present study 
reports on the relationships between clinical, parasitological, serological and entomological markers of malaria trans-
mission in an area of low transmission intensity in Coastal Kenya.
Methods: Longitudinal data collected from 831 children aged 5–17 months, cross-sectional survey data from 800 
older children and adults, and entomological survey data collected in Ganze on the Kenyan Coast were used in the 
present study. The spatial scan statistic test used to detect malaria transmission hotspots was based on incidence of 
clinical malaria episodes, prevalence of asymptomatic asexual parasites carriage detected by microscopy and poly-
merase chain reaction (PCR), seroprevalence of antibodies to two Plasmodium falciparum merozoite antigens (AMA1 
and MSP1-19) and densities of Anopheles mosquitoes in CDC light-trap catches.
Results: There was considerable overlapping of hotspots by these different markers, but only weak to moderate cor-
relation between parasitological and serological markers. PCR prevalence and seroprevalence of antibodies to AMA1 
or MSP1-19 appeared to be more sensitive markers of hotspots at very low transmission intensity.
Conclusion: These findings may support the choice of either serology or PCR as markers in the detection of malaria 
transmission hotspots for targeted interventions.
Keywords: Malaria, Hotspots, Spatial scan statistic, Antibodies, Serology, Asymptomatic parasitemia, Transmission, 
Targeted intervention
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Background
“Malaria hotspots” are defined as geographical areas 
within a wider area of transmission in which the trans-
mission intensity is significantly higher than the 
average level in the surrounding area of that setting and 
are widely observed in malaria endemic regions [1]. Sta-
ble and unstable hotspots have been reported in Kilifi [2] 
and they occur at various scales ranging from regional to 
homestead level [3].
Factors that are likely to determine the risk and spread 
of malaria include environmental factors such as tem-
perature, altitude, distance to water bodies, wind direc-
tion, and urbanization [4–6]. They also include intrinsic 
human characteristics, such as red blood cell genetic 
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polymorphisms, differential host attractiveness to 
Anopheles mosquitoes, fetal haemoglobin and dietary 
factors in early infancy, and extrinsic factors such as agri-
cultural practices, socio-economic factors, housing, level 
of education and behaviour [7–15].
Hotspots represent an opportunity for targeted con-
trol interventions that are expected to be more efficient 
than untargeted interventions and ultimately benefit the 
whole community [16].
Challenges in the identification of hotspots of trans-
mission include the choice of the transmission marker to 
measure, the choice of the geospatial method of detection, 
the choice of the scale of detection, when to detect them 
and how stable they are [16, 17]. Asymptomatic parasite 
carriage, clinical malaria episodes, vector biting intensi-
ties or antibody responses to selected malaria antigens 
have been proposed as potential markers of malaria trans-
mission in detecting hotspots in areas of low to moderate 
transmission intensity [18]. The exploration of PCR and 
serology as transmission markers has been especially sug-
gested in areas of unstable or very low transmission inten-
sity [19, 20].
In the present study, simultaneous measurements of 
several malaria transmission indicators were carried out 
in an area of low transmission including clinical, parasi-
tological, serological and entomological markers. These 
different markers were then used to detect malaria trans-
mission hotspots, to examine the spatial overlapping 
of the specific hotspots and to analyse the correlations 
between the markers. Ultimately, this study aims at pro-
viding additional evidence that might guide the choice of 
markers to be used in the detection of malaria transmis-
sion hotspots.
Methods
Ethical approval
The Kenya Medical Research Institute (KEMRI) Ethi-
cal Review Committee approved the Mal055 study (SSC 
1445) and the MTI study (SSC 2072). Study procedures 
were explained, and written informed consent was sought 
and obtained from each participant or his parents/guard-
ians (for children) prior to any study procedure. The study 
was conducted according to the Declaration of Helsinki.
Study area, population and surveillance method
The data used in the present study were taken from stud-
ies in Kilifi county on the Kenyan Coast. There were 
two cohorts monitored, one for clinical episodes during 
2 years of follow up and a second cohort monitored via 
cross-sectional surveys. The data were collected from 
January 2012 to December 2013 for the longitudinal 
monitoring and from July to September 2012 and May to 
July 2013 for the first and second cross-sectional surveys 
respectively.
831 children aged 5–17 months residing in 633 home-
steads were recruited into a randomized, controlled 
malaria vaccine trial in which longitudinal monitoring of 
malaria episodes was done [21]. Febrile malaria episodes 
were detected by passive case detection as previously 
described [21]. Clinical malaria was defined as the pres-
ence of fever (axillary temperature ≥37.5  °C) or history 
of fever in the past 24 h and parasitaemia ≥2500/μL [22].
In the same study area, two cross-sectional surveys 
involving 800 individuals (children and adults) were 
conducted in 2012 and 2013. The distribution of this 
population by age group is shown in Additional file  1. 
The homesteads, in which these participants were resid-
ing (211 and 183 in 2012 and 2013 respectively), were 
selected among 2456 homesteads recorded in sub-loca-
tions of the study administrative area by simple random 
sampling. The households involved in the malaria vac-
cine study were excluded. The cross-sectional surveys 
were used to measure asymptomatic parasitaemia, by 
microscopy of thick and thin blood smears and by PCR 
as described elsewhere [23], and IgG specific antibody 
responses to Plasmodium falciparum merozoite antigens 
[the apical membrane antigen 1 (AMA1) and the 19 kDa 
C-terminal region of the merozoite surface protein 1 
(MSP1-19)] as previously described [24]. Travel data 
were not recorded for any of these studies.
Data from an entomological study conducted in the 
same study area were also available for 2012 and 2013. 
Mosquito captures using CDC light traps were con-
ducted in 150 sampled houses, chosen at random, at six 
rounds covering the dry season, the long and the short 
rains. Anopheles gambiae and Anopheles funestus were 
the major human malaria vectors captured in the study 
area. The homesteads involved in the entomological 
study were not the same as those sampled for the clinical 
surveillance of children, and this limited the possibility to 
examine the association between household level mos-
quito exposure and household level malaria incidence. 
Longitude and latitude data for each homestead involved 
in the clinical and entomological studies were recorded 
during the surveys using handheld Garmin eTrex Global 
Positioning System devices. The study area, along with 
the distribution of the different homesteads involved, is 
illustrated in Fig. 1.
Detection of hotspots
Using the scan statistic method by Kulldorff [25], clusters 
of significantly higher risk of malaria than the remain-
ing surrounding study area were detected using clinical, 
biological and entomological markers. The following 
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markers were examined: clinical malaria, positive blood 
films, positive PCR tests, seropositivity to AMA1 and 
MSP1-19 and densities of Anopheles mosquitoes. The cut 
offs for seropositivity to AMA1 and MSP1-19 in normal-
ized optical density were, respectively 0.132 and 0.108 in 
2012, and 0.091 and 0.13 in 2013; they were determined 
using previously described methods [26]. The application 
of the scan statistic by SaTScan has been described pre-
viously [25]. Briefly, a scanning window (set to “circular” 
in the present analysis) is moved across the study area, 
and the maximum number of events that are captured by 
the window is recorded. The maximum window size was 
set to 30 % of the population at risk. Each of the different 
scanning windows was evaluated as a potential cluster by 
the calculation of a likelihood ratio test statistic based on 
the observed, expected and total number of cases. The 
corresponding p value is calculated using a Monte Carlo 
method.
To detect hotspots of clinical malaria cases, we used a 
discrete Poisson model where the cases were the clinical 
malaria cases detected in each homestead; population was 
defined as all monitored individuals residing in the corre-
sponding homesteads. A Bernoulli probability model was 
used to detect hotspots of positive blood films, hotspots 
of positive PCR tests and hotspots of individuals seroposi-
tive for AMA1 and MSP1-19. Cases were defined as indi-
viduals with a positive test (blood film, PCR or ELISA) in 
each homestead; the controls were defined as the individ-
uals with negative tests in the corresponding homesteads. 
A discrete Poisson model, in which the cases were the 
Anopheles mosquitoes captured in each house, was used 
to detect hotspots of Anopheles mosquitoes; the popula-
tion was defined as one individual per house.
For each detected hotspot, a relative risk (RR) was 
computed. The RR is the magnitude of the risk of malaria 
for individuals residing within the hotspot compared 
Fig. 1 Study area. Panels a and b show respectively a map of Kenya with a focus on Kilifi County and a map of Kilifi County highlighting the study 
area. On panel c, each dot represents the location of a homestead. The colors uniquely identify the studies. The different sizes of the dots help distin-
guish very close homesteads
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with those residing outside the hotspot. It is calculated 
as the ratio of the estimated risk within the hotspot and 
the estimated risk in the surrounding area. The estimated 
risk is calculated as the number of observed cases divided 
by the number of expected cases if the null hypothesis 
was true i.e. if the distribution of cases was totally ran-
dom. The threshold for statistical significance of the hot-
spots was set to 0.05.
Two hotspots overlap when the distance between 
their centres is smaller than the sum of their radii. The 
degree of overlapping of hotspots was estimated by cal-
culating, for a given couple of hotspots, the ratio of the 
common surface area by the total surface area of the 
smallest hotspot. The common surface area (A) of the 
intersecting hotspots is given by the following formula 
[27]:
where R and r are the radii of the hotspots and d the dis-
tance between their centres. When the smallest hotspot 
is entirely covered by the bigger hotspot with no inter-
section or when two concentric hotspots exactly over-
lap, a ratio = 1 is assigned.
Observations with missing coordinates data were 4.5, 
3 and  <1  % for serological, entomological and clinical 
surveillance data respectively; they were dropped prior 
to any analysis. Missing data for Anopheles mosquito 
capture and AMA1/MSP1-19 serology were <1 % in the 
respective datasets.
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Statistical analysis
To examine the distribution of the markers of malaria 
transmission, the data were summarized at homestead 
level by calculating sum of clinical malaria cases, sum of 
positive blood films, sum of positive PCR tests and geo-
metric mean antibody titre.
The data were then aggregated using a raster map of 
the study area derived from a Kilifi county administra-
tive map  (see Additional file  2); the original shapefile 
was downloaded from [28]. The resolution of the raster 
surface was set to 0.9 km. At this resolution and for each 
marker, each homestead was assigned to a unique cell 
by computing the shortest distance between the index 
homestead and the surrounding grid points. The values of 
each of the markers at homestead level were then aggre-
gated at grid cell level. The statistics used to aggregate the 
markers were the mean for counts of positive blood films 
and positive PCR tests, the weighted mean for count of 
clinical malaria cases and the weighted geometric mean 
for antibody titres. This aggregation was repeated for 
each year. The spatial correlations between these mark-
ers were examined using Spearman’s rank correlation 
coefficient on the aggregated data. SaTScan™ v9.4.1 was 
used to detect the hotspots and Stata 13.1 for Windows, 
StataCorp LP was used to perform the data analysis and 
produce the maps.
Results
Malaria morbidity and transmission indicators in the study 
area
The clinical, parasitological, serological and entomologi-
cal markers measured in these studies are summarized in 
Table 1 Yearly summary of clinical, parasitological, serological and entomological markers in the study area
Year 2012 2013
Longitudinal study Homesteads/population 633/831 633/831
Homesteads with malaria 65 (10.3 %) 22 (3.5 %)
Malaria cases 112 (13.5 %) 28 (3.4 %)
Cross-sectional studies Homesteads/population 211/779 183/797
Homesteads with positive blood films 8 (3.8 %) 2 (1.1 %)
Homesteads with positive PCR tests 31 (14.7 %) 22 (12 %)
Prevalence asymptomatic infection (microscopy), (95 % CI) 2 % (1.2–3.2) 0.2 % (0.03–0.9)
Prevalence asymptomatic infection (PCR), (95 % CI) 6.2 % (4.6–8) 3.3 % (2.2–4.8)
Seroprevalence of antibodies to AMA1, (95 % CI) 36.1 % (32.7–39.5) 20.4 % (17.7–23.4)
Seroprevalence of antibodies to MSP1-19, (95 % CI) 19.9 % (17.1–22.9) 10.5 % (8.5–12.9)
Entomological surveys Homesteads 145 142
Homesteads with Anopheles 35 (24 %) 8 (6 %)
Range of Anopheles captured/house 0–17 0–6
Total Anopheles captured 101 15
Total An. gambiae captured 85 5
Total An. funestus captured 16 10
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Table 1. Malaria transmission intensity was low in 2012 
with parasite rate by microscopy at 2  % in the general 
population, and declined further to 0.2 % in 2013. Simi-
larly, there was a decline in densities of malaria vectors 
in the study area in 2013 with Anopheles mosquitoes cap-
tured in only 6 % of the surveyed houses compared with 
24 % in 2012.
Malaria hotspots in the study area
For clinical malaria, asymptomatic parasitaemia deter-
mined by microscopy and Anopheles mosquitoes cap-
tures, there were fewer positive cases in 2013 compared 
to 2012 (Table  1) and fewer hotspots were identified 
(Figs.  2, 3, 4). In 2013, the PCR and AMA1, but not 
MSP1-19, hotspots were reduced to 10  % and 21  % of 
their size  in 2012 respectively (Figs. 5, 6, 7); the clinical 
malaria and mosquito vector hotspots were limited to 
single homesteads (Figs. 2, 4). There was one stable hot-
spot of clinical malaria (Fig. 2) in terms of position and 
size, limited to a single homestead, but the three other 
hotspots identified in 2012 were not identified in 2013. 
No hotspots of asymptomatic parasitaemia detected by 
microscopy was observed in 2013 (Fig. 3).     
The sampling of homesteads for the cross-sectional 
surveys differed between 2012 and 2013 (Fig.  1). How-
ever the hotspot of asymptomatic parasitaemia detected 
by PCR in 2012 overlapped 39  % of the one identified 
in 2013 (see Additional files 3 and 4). Moreover, glob-
ally, the hotspots of children seropositive to AMA1 
overlapped 100  % and 38  % of the hotspots of children 
seropositive to MSP1-19 in 2012 and 2013 respectively. 
When the marker used was seropositivity to both AMA1 
Fig. 2 Hotspots of clinical malaria cases. Each blue circle represents a statistically significant hotspot with its relative risk (RR) and p value displayed 
beside the circle
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and MSP1-19, the hotspots detected in 2012 globally 
overlapped 100 % and 4.4 % of the hotspots of individu-
als seropositive to MSP1-19 and AMA1 respectively. In 
2013, the pattern was reversed with the hotspot of chil-
dren seropositive to both AMA1 and MSP1-19 overlap-
ping 100 % and 57 % of hotspots of children seropositive 
to AMA1 and MSP1-19  respectively (see Additional 
file  5). There was one location in 2012 where the three 
types of serology hotspots (i.e. seropositive to AMA1, 
seropositive to MSP1-19 and seropositive to both AMA1 
and MSP1-19) exactly overlapped each other (see Addi-
tional file 5).
Variable overlapping of hotspots of clinical and parasi-
tological markers of transmission occurred in 2012 (see 
Additional files 6 and 7). Two hotspots of clinical malaria 
and two hotspots of Anopheles mosquitoes, limited to 
single-homesteads, did not overlap the hotspot deter-
mined by positive PCR tests. The hotspot of asympto-
matic parasitaemia detected by microscopy was totally 
contained within the hotspot determined by positive PCR 
tests.
Although the data were collected from different sam-
ples of homesteads for the different markers, these 
homesteads were all contained within the same sin-
gle study area. The different hotspots were visualized 
together to further investigate the extent of intersection 
and overlapping between them (see Additional file  8). 
Most hotspots concentrated in the southern part of 
the study area in 2012 and moved towards the north-
ern part in 2013. Seventy-one and sixty-six percent of 
hotspots overlapped with each other in 2012 and 2013 
respectively, irrespective of the markers. Considerable 
Fig. 3 Hotspots of asymptomatic malaria infections detected by light microscopy. Each blue circle represents a statistically significant hotspot with 
its relative risk (RR) and p value displayed beside the circle. No hotspot was identified in 2013
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overlapping was observed between the different hot-
spots as detailed in Additional files 7 and 9. The sub-
stantial overlapping of the AMA1 hotspot with that of 
asymptomatic infections detected by PCR observed in 
2012 was also observed in 2013 when the transmission 
declined further.
Spatial correlations between markers of malaria 
transmission
The distribution of the different markers is shown in 
Additional files 10 and 11. With the exception of Anoph-
eles mosquito densities, weak to moderate statistically 
significant correlations were found between the other 
markers of transmission in 2012 when the markers were 
averaged at grid cell level (see Table  2 and Additional 
file 12). Clinical malaria was weakly correlated with posi-
tive blood films (r2 = 0.07) but not with any other marker. 
Serological markers were better correlated with asymp-
tomatic parasitaemia detected by PCR (r2  >  0.29) than 
with asymptomatic parasitaemia detected by micros-
copy (r2 < 0.13). Asymptomatic parasitaemia detected by 
microscopy was correlated with asymptomatic parasitae-
mia detected by PCR (r2 =  0.26) and serological mark-
ers correlated with each other (r2  =  0.40). However, in 
2013, when the transmission intensity declined further, 
the only statistically significant correlations observed 
were between asymptomatic parasitaemia detected 
by microscopy and positive PCR tests (r2  =  0.11), and 
between antibodies to MSP1-19 and Anopheles mosqui-
toes (r2 = 0.34) (Table 3). 
Discussion
The present study describes the fine-scale spatial distri-
bution of P. falciparum malaria, examining the relation-
ships between different markers of malaria transmission 
in an area on the coast of Kenya. The levels of malaria 
transmission markers seen in this study were lower in 
2013 compared with 2012. The low number of asymp-
tomatic infections detected by microscopy prevented 
us having enough power to detect hotspots in 2013, 
but we could still detect hotspots with the larger num-
ber of positives seen by PCR. Most of the hotspots were 
unstable (i.e. inconsistent in location between 2012 and 
2013), but one hotspot of clinical malaria was main-
tained in its position and size over the 2 years. When the 
transmission intensity declined, the spatial correlations 
observed between the markers were reduced to correla-
tions between parasitological markers on the one hand, 
and serological and entomological markers on the other 
hand.
The decline of malaria transmission observed in the 
present study seems opposite to the observed trends of P. 
falciparum parasite rates along the coast [29]. However, 
this study was conducted in a restricted area and previ-
ous studies have reported high rates of heterogeneity in 
malaria transmission in the region, and that differing 
trends can be observed in sub-locations within the same 
area [3].
From 2012 to 2013, 57 % of hotspots disappeared and 
among the remaining ones, only PCR and serology hot-
spots maintained a size above the homestead level; the 
Fig. 4 Hotspots of Anopheles mosquitoes. Anopheles gambiae and 
Anopheles funestus were the only human malaria vector species 
captured during the survey. The orange and black circles represent the 
statistically significant hotspots of Anopheles mosquitoes in 2012 and 
2013 respectively. Each hotspot is displayed with its malaria relative 
risk (RR) and p value
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other hotspots shrank to single homesteads. Hotspots of 
asymptomatic parasite carriers detected by microscopy 
were not seen in 2013 despite ongoing transmission evi-
denced by clinical malaria cases. This suggests that cross-
sectional surveys using microscopy may not be ideal 
when transmission intensity declines to very low levels 
[30]. The hotspots that persisted were asymptomatic par-
asite carriers detected by PCR and serological methods, 
suggesting these markers as good candidates for sensi-
tive hotspot detection in settings with declining malaria 
transmission.
In 2012, there was a total overlap of hotspots of asymp-
tomatic parasite carriers detected by microscopy with 
hotspots of asymptomatic parasite carriers detected by 
PCR as expected, especially given that the sensitivity of 
PCR is higher than that of light microscopy [31]. This is 
consistent with the statistically significant spatial cor-
relation observed between these markers when the data 
were analysed at grid cell level. On the other hand, epi-
demiological studies have shown that parasite density 
can be inversely proportional to the intensity of trans-
mission at a micro-epidemiological scale [32], and this 
might have led microscopy-defined hotspots to be differ-
ently located from PCR-defined hotspots. In the present 
study the transmission intensity was much lower and this 
phenomenon was not observed. The hotspots of asymp-
tomatic parasite carriers detected by PCR overlapped 
the hotspots detected by serological markers in 2012 and 
2013, supporting the idea of using serological markers as 
an alternative to PCR in the detection of hotspots. It has 
Fig. 5 Hotspots of asymptomatic malaria infections detected by polymerase chain reaction (PCR). Each blue circle represents a statistically signifi-
cant hotspot with its relative risk (RR) and p value displayed beside the circle
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been shown previously that children living in hotspots of 
asymptomatic parasitaemia have higher antibody titres 
compared with those living in clinical malaria hotspots 
[2], and antibody titres have been described as a marker 
of exposure [33].
One clinical malaria hotspot was found to be stable 
across the 2  years, which is not consistent with previ-
ous reports in which hotspots of clinical malaria were 
found to be unstable compared with hotspots of asymp-
tomatic parasitaemia [2]. However, the short period of 
observation in the present study and the low age of chil-
dren assessed (i.e. 5–17 months olds) in a low transmis-
sion setting are the likely explanation of this observation 
since immunity to clinical malaria builds up over a much 
longer period at lower transmission intensities [34, 35].
The relative simplicity and lower cost of serology com-
pared with PCR may make the use of serological markers 
more attractive for large-scale surveillance. However the 
fact that serological surveys may not distinguish recent 
from medium-term exposure may be a disadvantage, 
since the location of hotspots may vary from year to year. 
This could be overcome by including only young chil-
dren in the surveys [36] whose antibody responses have 
been attributed to short-lived plasma cells [37, 38] or by 
measuring responses to antigens for which evidence sug-
gest that they have limited capacity to induce long-lived 
plasma cells [39]. Helb et al. have recently reported that 
antibody responses to some novel malaria antigens can 
limit detection to infections occurring within the last 
30 days [40].
Fig. 6 Hotspots of individuals seropositive to Plasmodium falciparum apical membrane antigen 1 (AMA1). Each blue circle represents a statistically 
significant hotspot with its relative risk (RR) and p value displayed beside the circle
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The present study was opportunistic based on the 
availability of datasets and thus presents with some 
limitations. The sampled homesteads were not the 
same for the entomological, serological and clinical 
surveillance studies and this prevents us from exam-
ining homestead-level correlations in more detail. The 
sample size was not large and the limited period of 
observation does not allow a definitive assessment of 
temporal stability.
Conclusions
The global decline of malaria transmission and plans 
for elimination have led to increased interest in 
the fine-scale epidemiology of malaria. One of the 
challenges in targeted interventions is the appropriate 
detection of residual transmission foci at the pre-elim-
ination stage. The choice of a cost-effective marker 
that can be logistically feasible and readily imple-
mented across sites by malaria control programmes 
would be important in the elimination efforts as well 
as the post-elimination surveillance. These findings 
may support the choice of either serology or PCR as 
markers in the detection of transmission hotspots for 
targeted interventions.
Availability of supporting data
The supporting data are under the custodianship 
of the KEMRI-Wellcome Trust Data Governance 
Fig. 7 Hotspots of individuals seropositive to Plasmodium falciparum merozoite surface protein 1 (MSP1-19). Each blue circle represents a statistically 
significant hotspot with its relative risk (RR) and p value displayed beside the circle
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Table 2 Correlations between malaria transmission markers in 2012 at 0.9 km resolution
All markers are expressed as average per cell of a 0.9 km resolution grid superimposed on the study area. Positive blood films, positive PCR tests and Anopheles 
mosquitoes captured are expressed as mean/grid cell. Antibody titres are expressed as weighted geometric mean/grid cell. Clinical malaria cases are expressed as 
weighted mean/grid cell. For each pair of markers the table reports from top to bottom the correlation coefficient (rs), the number of grid cells (n) and the p value for rs
Clinical malaria 
cases
Positive blood 
films
Positive PCR tests Anti-AMA1 anti-
body titres
Anti-MSP1-19 
antibody titres
Anopheles mosqui-
toes captured
Clinical malaria cases 1
266
Positive blood films 0.2672 1
266 292
<0.0001
Positive PCR tests 0.0328 0.5114 1
266 292 292
0.5944 <0.0001
Anti-AMA1 antibody 
titres
0.0215 0.2927 0.5413 1
41 42 42 43
0.8937 0.06 0.0002
Anti-MSP1-19 anti-
body titres
−0.0444 0.3509 0.5745 0.6338 1
41 42 42 43 43
0.7828 0.0227 0.0001 <0.0001
Anopheles mosqui-
toes captured
0.0929 0.0648 −0.2398 −0.0218 1
87 87 87 20 20 90
0.3923 0.5513 0.3086 0.9272
Table 3 Correlations between malaria transmission markers in 2013 at 0.9 km resolution
All markers are expressed as average per cell of a 0.9 km resolution grid superimposed on the study area. Positive blood films, positive PCR tests and Anopheles 
mosquitoes captured are expressed as mean/grid cell. Antibody titres are expressed as weighted geometric mean/grid cell. Clinical malaria cases are expressed as 
weighted mean/grid cell. For each pair of markers the table reports from top to bottom the correlation coefficient (rs), the number of grid cells (n) and the p value for rs
Clinical malaria 
cases
Positive blood 
films
Positive PCR tests Anti-AMA1 anti-
body titres
Anti-MSP1-19 
antibody titres
Anopheles mosqui-
toes captured
Clinical malaria cases 1
266
Positive blood films −0.0165 1
266 292
0.7884
Positive PCR tests 0.057 0.3295 1
266 292 292
0.3544 <0.0001
Anti-AMA1 antibody 
titres
−0.0339 0.0516 0.002 1
22 22 22 22
0.8808 0.8196 0.9931
Anti-MSP1-19 anti-
body titres
−0.2376 0.0172 −0.0773 −0.0627 1
22 22 22 22 22
0.2869 0.9394 0.7323 0.7817
Anopheles mosqui-
toes captured
0.1693 −0.0343 0.116 0.1943 0.583 1
87 87 87 12 12 90
0.1169 0.7527 0.2846 0.5451 0.0467
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Additional files
Additional file 1. Distribution of study population by age groups in the 
cross-sectional surveys.
Additional file 2. Tessellation of the study area and densities of home-
steads. Each grid cell is a 0.9 × 0.9 km square. In figure A the green dots 
represent the homesteads. In figure B the shades of green color are pro-
portional to the densities of homesteads with darker shades representing 
higher densities.
Additional file 3. Dynamics of hotspots of asymptomatic parasite carri-
ers detected by PCR.
Additional file 4. Overlapping of malaria transmission hotspots detected 
in 2012 with those detected in 2013. Empty cells indicates no intersection 
and no overlapping was observed i.e. d > R + r. A ratio = 1 indicates a 
total overlapping i.e. d = 0 and R = r, or d < R - r, where d is the distance 
between the centres of two given hotspots, R and r the radii of these 
hotspots. HS index hotspot index in relation to Additional file 8.
Additional file 5. Spatial overlapping of hotspots of serological markers 
of malaria transmission. Each green dot represents a homestead. The 
homesteads sampled in 2012 differed from those sampled in 2013.
Additional file 6. Spatial overlapping of hotspots of clinical and parasito-
logical markers of malaria transmission. The homesteads sampled in 2012 
were the same as those sampled in 2013 for the longitudinal study.
Additional file 7. Overlapping of malaria transmission hotspots in 2012. 
Empty cells indicate no intersection and no overlapping was observed i.e. 
d > R + r. A ratio = 1 indicates a total overlapping i.e. d = 0 and R = r, or 
d < R - r, where d is the distance between the centres of two given hot-
spots, R and r the radii of these hotspots. HS index hotspot index in relation 
to Additional file 8. NA not applicable.
Additional file 8. Summary of the spatial overlapping of hotspots of 
malaria transmission markers. Each green spot represents a homestead. All 
homesteads involved in the clinical surveillance, serology and entomol-
ogy studies and the specific hotspots are superimposed on the same map 
for each year.
Additional file 9. Overlapping of malaria transmission hotspots in 2013. 
Empty cells indicate no intersection and no overlapping was observed i.e. 
d > R + r. A ratio = 1 indicates a total overlapping i.e. d = 0 and R = r, or 
d < R - r, where d is the distance between the centres of two given hot-
spots, R and r the radii of these hotspots. HS index hotspot index in relation 
to Additional file 8. NA not applicable.
Additional file 10. Distribution of antibody titres to AMA1 and MSP1-19. 
The data are aggregated at homestead level.
Additional file 11. Distribution of clinical, parasitological and ento-
mological markers of malaria transmission. The data are aggregated at 
homestead level.
Additional file 12. Correlations between clinical, parasitological, sero-
logical and entomological malaria transmission markers. All markers are 
expressed as average per cell of a 0.9 km resolution grid superimposed 
on the study area. Positive blood films, positive PCR tests and Anopheles 
mosquitoes captured are expressed as mean/grid cell. Antibody titres are 
expressed as weighted geometric mean/grid cell. Clinical malaria cases 
are expressed as weighted mean/grid cell.
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